Clinical Observation on Acute Myeloid Leukemia Treated by Combination of Traditional Chinese and Western Medicine
Download as PDF
Objective: To study the value of integrated traditional Chinese and western medicine in acute myeloid leukemia. Methods: 58 patients with acute myeloid leukemia admitted to our hospital from May 2017 to June 2019 were divided into experimental group and control group (n=29) by computer random double blind method. The experimental group was treated with integrated traditional Chinese and western medicine, while the control group was treated with conventional therapy. Contrast immune function and other indicators. Results: at the end of the treatment, the levels of CD3 +, CD4 +, CD4 + / CD8 + were (63.42 ± 6.94)%, 33.47 ± 5.01)%, 1.03 ± 0.13%, higher than those of the control group (56.48 ± 6.02)%, (28.29 ± 3.68)%, (0.91 ± 0.08)%, P < 0.05. EORTC qoq-c30 score (82.47 ± 3.96) at the end of treatment in the experimental group was better than that in the control group (73.11 ± 4.25), P < 0.05. The total effective rate of the test group was 93.10%, which was higher than the control group of 72.41%, P <0.05. Conclusion: The application of integrated traditional Chinese and western medicine in acute myeloid leukemia can significantly improve the efficacy, promote the recovery of immune function and improve the quality of life. It is recommended to promote it.
Acute myeloid leukemia, Immune function, Integrated traditional chinese and western medicine therapy, Curative effect